Moon Sung K, Woo Jeong-Im, Lee Haa-Yung, Park Raekil, Shimada Jun, Pan Huiqi, Gellibolian Robert, Lim David J
The Gonda Department of Cell and Molecular Biology, House Ear Institute, 2100 West 3rd Street, Los Angeles, CA 90057, USA.
Infect Immun. 2007 Jul;75(7):3361-72. doi: 10.1128/IAI.01886-06. Epub 2007 Apr 23.
Inner ear dysfunction secondary to chronic otitis media (OM), including high-frequency sensorineural hearing loss or vertigo, is not uncommon. Although chronic middle ear inflammation is believed to cause inner ear dysfunction by entry of OM pathogen components or cytokines from the middle ear into the inner ear, the underlying mechanisms are not well understood. Previously, we demonstrated that the spiral ligament fibrocyte (SLF) cell line up-regulates monocyte chemotactic protein 1 (MCP-1) expression after treatment with nontypeable Haemophilus influenzae (NTHI), one of the most common OM pathogens. We hypothesized that the SLF-derived MCP-1 plays a role in inner ear inflammation secondary to OM that is responsible for hearing loss and dizziness. The purpose of this study was to investigate the signaling pathway involved in NTHI-induced MCP-1 up-regulation in SLFs. Here we show for the first time that NTHI induces MCP-1 up-regulation in the SLFs via Toll-like receptor 2 (TLR2)-dependent activation of NF-kappaB. TLR2(-/-)- and MyD88(-/-)-derived SLFs revealed involvement of TLR2 and MyD88 in NTHI-induced MCP-1 up-regulation. Studies using chemical inhibitors and dominant-negative constructs demonstrated that it is mediated by the IkappaKbeta-dependent IkappaBalpha phosphorylation and NTHI-induced NF-kappaB nuclear translocation. Furthermore, we demonstrated that the binding of NF-kappaB to the enhancer region of MCP-1 is involved in this up-regulation. In addition, we have identified a potential NF-kappaB motif that is responsive and specific to certain NTHI molecules or ligands. Further studies are necessary to reveal specific ligands of NTHI that activate host receptors. These results may provide us with new therapeutic strategies for prevention of inner ear dysfunction secondary to chronic middle ear inflammation.
继发于慢性中耳炎(OM)的内耳功能障碍,包括高频感音神经性听力损失或眩晕,并不少见。尽管人们认为慢性中耳炎症是通过中耳病原体成分或细胞因子进入内耳而导致内耳功能障碍,但其潜在机制尚未完全了解。此前,我们证明了螺旋韧带成纤维细胞(SLF)系在用不可分型流感嗜血杆菌(NTHI,最常见的OM病原体之一)处理后会上调单核细胞趋化蛋白1(MCP-1)的表达。我们假设SLF衍生的MCP-1在继发于OM的内耳炎症中起作用,而这种炎症是导致听力损失和头晕的原因。本研究的目的是调查参与NTHI诱导SLF中MCP-1上调的信号通路。在此我们首次表明,NTHI通过Toll样受体2(TLR2)依赖性激活核因子κB(NF-κB)诱导SLF中MCP-1上调。来自TLR2(-/-)和髓样分化因子88(MyD88)(-/-)的SLF显示TLR2和MyD88参与NTHI诱导的MCP-1上调。使用化学抑制剂和显性负性构建体的研究表明,它是由IκB激酶β(IκKβ)依赖性IκBα磷酸化和NTHI诱导的NF-κB核转位介导的。此外,我们证明NF-κB与MCP-1增强子区域的结合参与了这种上调。此外,我们已经鉴定出一个潜在的NF-κB基序,它对某些NTHI分子或配体有反应且具有特异性。需要进一步研究以揭示激活宿主受体的NTHI特异性配体。这些结果可能为我们提供预防继发于慢性中耳炎症的内耳功能障碍的新治疗策略。